← All Sponsors
SPONSOR

Tongji Hospital

Total Trials
13
Recruiting
13
Phases
Phase 2, Phase 1, EARLY_Phase 1

Tongji Hospital is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Familial Mediterranean Fever (FMF ), Segmentation, Esophageal Squamous Cell Carcinoma, Liver Cancer (Primary and Metastatic).

The trial portfolio spans Phase 2, Phase 1, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Tongji Hospital

How many clinical trials has Tongji Hospital sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by Tongji Hospital, of which 13 are actively recruiting participants. These trials cover conditions including Familial Mediterranean Fever (FMF ), Segmentation, Esophageal Squamous Cell Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tongji Hospital research focus on?
Tongji Hospital clinical trials span Familial Mediterranean Fever (FMF ), Segmentation, Esophageal Squamous Cell Carcinoma, Liver Cancer (Primary and Metastatic), Neuromyelitis Optica Spectrum Disorders, and additional conditions. The research pipeline includes Phase 2, Phase 1, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Tongji Hospital clinical trial?
To participate in a Tongji Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tongji Hospital trials with current recruitment status updated daily.

Clinical Trials by Tongji Hospital

NCT07077473
Recruiting

Observing the Efficacy and Safety of Different Drugs Used in Real-world Familial Mediterranean Fever (FMF) Cases

Familial Mediterranean Fever (FMF )
NCT06646679
Recruiting

Intelligent Segmentation Algorithm of Ultrasonic Image

Segmentation
NCT07699185 Phase 2
Recruiting

Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma
NCT07587216
Recruiting

Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment

Liver Cancer (Primary and Metastatic)
NCT06620809 Phase 1
Recruiting

The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

Neuromyelitis Optica Spectrum Disorders
NCT06467773
Recruiting

TSPO-PET/MRI in Surveillance of Neuroinflammation in the Central Nervous System

Central Nervous System Diseases
NCT07088354
Recruiting

Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Esophageal Squamous Cell Carcinoma
NCT06525909
Recruiting

A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B

Hepatitis B, Chronic
NCT05520788
Recruiting

Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing

Hepatocellular Carcinoma
NCT06497361 EARLY_Phase 1
Recruiting

Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease

Lupus Nephritis
NCT07128186
Recruiting

The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus

Cognitive Dysfunction
NCT07646730
Recruiting

Wearable Device-Based Early Warning of Postoperative Complications in Thoracic Surgery

Postoperative Complications
NCT07392567
Recruiting

Prospective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer

Colorectal Cancer Liver Metastasis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology